In contrast, the complete response rate was only 11% in aged mice after treatment with the combination of anti-PD-L1 and anti-CTLA-4 antibodies (Figure 4C) and there was a significant decrease in the effect of the treatment on tumor growth rates (Figure 4D p=0.0002). Here, CTLA4 is linked to neoplasm.